References
- O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106–10. doi:https://doi.org/10.1038/nature05372
- Jacouton E, Chain F, Sokol H, Langella P, Bermudez-Humaran LG. Probiotic strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer. Front Immunol. 2017;8:1553.
- Dunlop MG, British Society for G, Association of Coloproctology for Great B, Ireland. Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years. Gut. 2002;51(Suppl 5):V17–20. doi:https://doi.org/10.1136/gut.51.suppl_5.v17
- Azcarate-Peril MA, Sikes M, Bruno-Barcena JM. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol. 2011;301(3):G401–24. doi:https://doi.org/10.1152/ajpgi.00110.2011
- Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr. 2000;130(2S Suppl):403S–9S. doi:https://doi.org/10.1093/jn/130.2.403S
- Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–23. doi:https://doi.org/10.1038/nri2515
- Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 2002;4(3):319–24. doi:https://doi.org/10.1016/S1286-4579(02)01544-7
- Chen CC, Louie S, Shi HN, Walker WA. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res. 2005;58(6):1185–91. doi:https://doi.org/10.1203/01.pdr.0000183660.39116.83
- Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453(7195):620–5. doi:https://doi.org/10.1038/nature07008
- de Moreno de LeBlanc A, Matar C, Farnworth E, Perdigon G. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine. 2006;34(1-2):1–8. doi:https://doi.org/10.1016/j.cyto.2006.03.008
- de Moreno de LeBlanc A, Matar C, Theriault C, Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology. 2005;210(5):349–58. doi:https://doi.org/10.1016/j.imbio.2005.05.024
- Foster LM, Tompkins TA, Dahl WJ. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Benef Microbes. 2011;2(4):319–34. doi:https://doi.org/10.3920/BM2011.0032
- Ali MS, Hussein RM, Gaber Y, Hammam OA, Kandeil MA. Modulation of JNK-1/β-catenin signaling by Lactobacillus casei, inulin and their combination in 1,2-dimethylhydrazine-induced colon cancer in mice†. RSC Adv. 2019;9(50):29368–83. doi:https://doi.org/10.1039/C9RA04388H
- Rahimi AM, Nabavizadeh F, Ashabi G, Halimi S, Rahimpour M. Probiotic Lactobacillus rhamnosus supplementation improved capecitabine protective effect against gastric cancer Growth in male BALB/c mice. Nutr Cancer. 2020;1–11.
- Zhou J, Wang Y, Xiong Y, Wang H, Feng Y, Chen J. Delivery of Tfpi-2 using ultrasound with a microbubble agent (sonovue) inhibits intimal hyperplasia after balloon injury in a rabbit carotid artery model. Ultrasound Med Biol. 2010;36(11):1876–83. doi:https://doi.org/10.1016/j.ultrasmedbio.2010.08.013
- An JM, Kang EA, Han Y-M, Oh JY, Lee DY, Choi SH, Kim DH, Hahm KB. Dietary intake of probiotic kimchi ameliorated IL-6-driven cancer cachexia. J Clin Biochem Nutr. 2019;65(2):109–17. doi:https://doi.org/10.3164/jcbn.19-10
- Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et al. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106–33. doi:https://doi.org/10.1016/j.critrevonc.2010.01.010
- Yu AQ, Li L. The potential role of probiotics in cancer prevention and treatment. Nutr Cancer. 2016;68(4):535–44. doi:https://doi.org/10.1080/01635581.2016.1158300
- Molska M, Reguła J. potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer. Nutrients. 2019;11(10):2453. doi:https://doi.org/10.3390/nu11102453
- McIntosh GH, Royle PJ, Playne MJ. A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer. 1999;35(2):153–9. doi:https://doi.org/10.1207/S15327914NC352_9
- Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M, Onoue M, Matsuoka Y, Ohwaki M, Morotomi M. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res. 2001;61(6):2395–8.
- Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74. doi:https://doi.org/10.1016/S1470-2045(11)70002-X
- Nakash O, Levav I, Aguilar-Gaxiola S, Alonso J, Andrade LH, Angermeyer MC, Bruffaerts R, Caldas-de-Almeida JM, Florescu S, de Girolamo G, et al. Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys. Psychooncology. 2014;23(1):40–51. doi:https://doi.org/10.1002/pon.3372
- Barzegar Behrooz A, Nabavizadeh F, Adiban J, Shafiee Ardestani M, Vahabpour R, Aghasadeghi MR, Sohanaki H. Smart bomb AS1411 aptamer-functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer. Clin Exp Pharmacol Physiol. 2017;44(1):41–51. doi:https://doi.org/10.1111/1440-1681.12670
- Ivanov II, Frutos R. d L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4(4):337–49. doi:https://doi.org/10.1016/j.chom.2008.09.009
- Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG-host interactions. Microb Cell Fact. 2014;13 Suppl 1 (Suppl 1):S7. doi:https://doi.org/10.1186/1475-2859-13-S1-S7
- Gamallat Y, Meyiah A, Kuugbee ED, Hago AM, Chiwala G, Awadasseid A, Bamba D, Zhang X, Shang X, Luo F, et al. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother. 2016;83:536–41. doi:https://doi.org/10.1016/j.biopha.2016.07.001
- Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16(2):153–66. doi:https://doi.org/10.1016/j.cmet.2012.06.011
- Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–98. doi:https://doi.org/10.1038/nrclinonc.2015.200
- de Moreno de Leblanc A, Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc. 2010;69(3):421–8. doi:https://doi.org/10.1017/S002966511000159X
- Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206(7):1457–64. doi:https://doi.org/10.1084/jem.20090207